UPDATE : Monday, February 17, 2020
상단여백
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits? by Kim Yun-mi 2020-01-14 15:28
Genexine becomes largest shareholder of GenNBio by Lee Han-soo 2020-01-14 11:11
Daewoong, A2A to develop AI-based anticancer treatment by Lee Han-soo 2020-01-14 10:35
GSK shows meaningful response rate for treatment of multiple myeloma by Lee Han-soo 2020-01-13 17:48
Zejula widens indication as monotherapy for ovarian cancer by Kim Yun-mi 2020-01-13 16:25
라인
Vivozon positive of Opiranserin’s efficacy despite failures to meet primary endpoint by Lee Han-soo 2020-01-13 16:22
Lilly secures atopic dermatitis drug through Dermira acquisition by Kim Yun-mi 2020-01-13 14:05
Latecomer Bavencio improves overall survival in bladder cancer trial by Kim Yun-mi 2020-01-10 14:23
HLB gets UAE’s nod for joint company with local partner by Lee Han-soo 2020-01-08 16:31
Daewoong, Avacta to establish joint venture by Lee Han-soo 2020-01-08 12:25
라인
Genexine licenses out immunosuppressant candidate to GenNBio by Lee Han-soo 2020-01-07 17:35
Mundipharma to market Biosolution's knee cartilage defect treatment by Lee Han-soo 2020-01-07 16:11
Fenbendazole craze expands to human parasiticide by Lee Han-soo 2020-01-07 12:33
Eliquis price cut delayed amid prolonged administrative suit by Kim Yun-mi 2020-01-07 11:32
Chinese drugmaker Mebo establishes branch in Korea by Lee Han-soo 2020-01-06 14:40
라인
[New Year Special] Boryung, Hanmi in fierce battle to fill ranitidine void by Jeong Sae-im 2020-01-03 17:56
Bukwang, Sanofi Aventis Korea to co-promote hypertension med by Lee Han-soo 2020-01-03 17:55
Daewoong launches oral typhoid fever vaccine by Lee Han-soo 2020-01-03 17:55
[New Year Special] Rise of digital therapeutics to change healthcare scene for good by Lee Han-soo 2020-01-03 14:57
SK Bioscience’s influenza vaccine nabs WHO certification by Lee Han-soo 2020-01-03 14:14
여백
여백
여백
Back to Top